Signaling through the neurotransmitter dopamine (DA) is critical for fundamental life processes across the animal kingdom, including motor control, behavior, and cognition. Disruption of DA function is associated with problems in motor activity (tremors, rigidity, etc.) such as occurs with the progressive neurodegeneration of DA neurons in Parkinson's disease. Understanding the modulation of DA neuron function, which can occur through control of DA synthesis, vesicle packaging, release, reception, reuptake, and/or metabolism, will give insight into new therapeutic strategies for DA-associated disorders.We are using Caenorhabditis elegans as a model to investigate the modulation of DA signaling. Our lab has discovered an important role for the transcription factor FKH-8 in C. elegans DA neuron function, as evidenced by a DA-dependent swimming-induced paralysis (SWIP) phenotype in mutants lacking FKH-8. The forkhead gene family encodes winged-helix transcription factors. One potential aspect of DA signaling regulation that I am exploring is regulation of DA metabolism by monoamine oxidases (MAOs), which help to degrade DA by clearing it from the synapse. It is possible that the hyper-dopaminergic phenotype of
fkh-8 mutants is due to a downstream loss of MAOs. Our initial data suggests that mutants for any of the 3 MAO-encoding genes (
amx-1, -2, or -3) display a SWIP phenotype, and we are currently generating
fkh-8;amx double mutant strains to determine if these genes are in the same pathway.Grant Number: 1R25GM107754-01 (NIH)Project Title: The Fisk-Vanderbilt Biomedical Bridge to the Doctorate.